应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
06998 亿腾嘉和
未开盘 09-02 16:08:07
1.610
+0.025
+1.58%
最高
1.650
最低
1.565
成交量
30.05万
今开
1.650
昨收
1.585
日振幅
5.36%
总市值
32.01亿
流通市值
32.01亿
总股本
19.88亿
成交额
48.35万
换手率
0.02%
流通股本
19.88亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
亿腾嘉和(06998.HK)8月31日斥资61.99万港元回购39.75万股
智通财经 · 09-01 06:36
亿腾嘉和(06998.HK)8月31日斥资61.99万港元回购39.75万股
亿腾嘉和(06998)8月31日斥资61.99万港元回购39.75万股
智通财经 · 09-01 06:36
亿腾嘉和(06998)8月31日斥资61.99万港元回购39.75万股
亿腾嘉和回购39.75万股股份,总额约61.99万港元
公告速递 · 09-01 06:11
亿腾嘉和回购39.75万股股份,总额约61.99万港元
亿腾嘉和(06998)公告:主席拟自8月31日起增持最高100万美元股份,公司同步启动回购
公告速递 · 08-31 23:07
亿腾嘉和(06998)公告:主席拟自8月31日起增持最高100万美元股份,公司同步启动回购
亿腾嘉和(06998)董事会主席倪昕计划斥资最高100万美元增持公司股份
智通财经 · 08-31 22:55
亿腾嘉和(06998)董事会主席倪昕计划斥资最高100万美元增持公司股份
亿腾嘉和(06998)发布中期业绩 期内亏损6587.6万元 同比盈转亏
智通财经 · 08-28
亿腾嘉和(06998)发布中期业绩 期内亏损6587.6万元 同比盈转亏
亿腾嘉和2026年上半年营收8.73亿元,经调整净亏损0.33亿元
公告速递 · 08-28
亿腾嘉和2026年上半年营收8.73亿元,经调整净亏损0.33亿元
亿腾嘉和(06998.HK)盈警:预计中期净亏损6000万元至7000万元
中金财经 · 08-21
亿腾嘉和(06998.HK)盈警:预计中期净亏损6000万元至7000万元
亿腾嘉和(06998.HK)发盈警,预期中期净亏损6000万元至7000万元 同比盈转亏
智通财经 · 08-21
亿腾嘉和(06998.HK)发盈警,预期中期净亏损6000万元至7000万元 同比盈转亏
亿腾嘉和(06998)发出盈利警告:上半年预计由盈转亏至最高亏损70百万元
公告速递 · 08-21
亿腾嘉和(06998)发出盈利警告:上半年预计由盈转亏至最高亏损70百万元
亿腾嘉和公告将于8月28日召开董事会审议中期业绩与派息事宜
公告速递 · 08-18
亿腾嘉和公告将于8月28日召开董事会审议中期业绩与派息事宜
亿腾嘉和(06998)GB268在乳腺癌Ib/II期试验完成首例给药
公告速递 · 08-06
亿腾嘉和(06998)GB268在乳腺癌Ib/II期试验完成首例给药
亿腾嘉和(06998):GB268 Ib/II期临床试验完成首例受试者给药
智通财经 · 08-06
亿腾嘉和(06998):GB268 Ib/II期临床试验完成首例受试者给药
亿腾嘉和更新7月股份变动月报表,股本总量保持不变
公告速递 · 08-06
亿腾嘉和更新7月股份变动月报表,股本总量保持不变
亿腾嘉和(06998)景助达再许可协议终止 已向关联方累计支付6,000万元
公告速递 · 08-05
亿腾嘉和(06998)景助达再许可协议终止 已向关联方累计支付6,000万元
亿腾嘉和回购20万股股份,总额约36.38万港元
公告速递 · 07-28
亿腾嘉和回购20万股股份,总额约36.38万港元
亿腾嘉和(06998.HK)7月28日斥资36.38万港元回购20万股
智通财经 · 07-28
亿腾嘉和(06998.HK)7月28日斥资36.38万港元回购20万股
亿腾嘉和回购74,000股,总额约13.99万港元
公告速递 · 07-27
亿腾嘉和回购74,000股,总额约13.99万港元
亿腾嘉和(06998)7月27日耗资约13.99万港元回购7.4万股
智通财经 · 07-27
亿腾嘉和(06998)7月27日耗资约13.99万港元回购7.4万股
亿腾嘉和于7月24日斥资37.26万港元回购20万股
新浪港股 · 07-26
亿腾嘉和于7月24日斥资37.26万港元回购20万股
加载更多
公司概况
公司名称:
亿腾嘉和
所属市场:
SEHK
上市日期:
--
主营业务:
亿腾嘉和医药集团有限公司(原名:嘉和生物药业(开曼)控股有限公司)是一家专注于生物制药业务的企业。该公司主营业务涵盖人用生物制药产品的研发、商业化及产业化。该公司产品管线包括来罗西利(GB491)、GB261、GB263T、英夫利西单抗(GB242)、Coprelotamab(GB221)、GB223、利妥昔单抗(GB241)等,涉及乳腺癌、肺癌、胃肠肿瘤及血液肿瘤等疾病领域。该公司主要在国内市场开展业务。
发行价格:
--
{"stockData":{"symbol":"06998","market":"HK","secType":"STK","nameCN":"亿腾嘉和","latestPrice":1.61,"timestamp":1788336487009,"preClose":1.585,"halted":0,"volume":300500,"delay":0,"changeRate":0.015772870662460654,"floatShares":1988000000,"shares":1988000000,"eps":0.235,"marketStatus":"未开盘","change":0.025,"latestTime":"09-02 16:08:07","open":1.65,"high":1.65,"low":1.565,"amount":483537,"amplitude":0.053628,"askPrice":1.645,"askSize":1000,"bidPrice":1.61,"bidSize":500,"shortable":3,"etf":0,"ttmEps":0.127,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788399000000},"marketStatusCode":0,"adr":0,"listingDate":1602000000000,"exchange":"SEHK","adjPreClose":1.585,"openAndCloseTimeList":[[1788312600000,1788321600000],[1788325200000,1788336000000]],"volumeRatio":0.4889358933752864,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/06998","defaultTab":"news","newsList":[{"id":"2664855886","title":"亿腾嘉和(06998.HK)8月31日斥资61.99万港元回购39.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664855886","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664855886?lang=zh_cn&edition=full","pubTime":"2026-09-01 06:36","pubTimestamp":1788215812,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1583","06998","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664688685","title":"亿腾嘉和(06998)8月31日斥资61.99万港元回购39.75万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664688685","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664688685?lang=zh_cn&edition=full","pubTime":"2026-09-01 06:36","pubTimestamp":1788215812,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亿腾嘉和(06998)发布公告,于2026年8月31日,该公司斥资61.99万港元回购39.75万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1490047.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1161","06998","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137345859","title":"亿腾嘉和回购39.75万股股份,总额约61.99万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1137345859","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137345859?lang=zh_cn&edition=full","pubTime":"2026-09-01 06:11","pubTimestamp":1788214261,"startTime":"0","endTime":"0","summary":"亿腾嘉和于2026年8月31日发布公告,称公司当日通过香港联交所场内回购普通股39.75万股,占回购前已发行股本约0.02%。回购价格介乎每股HKD1.47至HKD1.57,总支出约61.99万港元。本次回购完成后,公司已发行股本为1,988,102,274股,库存股数量为25,939,500股。公告显示,此次回购已于2026年6月26日获得股东大会授权,最高可回购股份总数为199,074,827股,截至本次回购前公司已合计回购2,646,000股,剩余可回购授权为196,428,827股。公司确认已遵守香港联交所证券上市规则及相关法律法规要求。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和回购39.75万股股份,总额约61.99万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136788803","title":"亿腾嘉和(06998)公告:主席拟自8月31日起增持最高100万美元股份,公司同步启动回购","url":"https://stock-news.laohu8.com/highlight/detail?id=1136788803","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136788803?lang=zh_cn&edition=full","pubTime":"2026-08-31 23:07","pubTimestamp":1788188821,"startTime":"0","endTime":"0","summary":"8月31日,亿腾嘉和医药集团有限公司发布自愿性公告称,董事会主席、执行董事兼首席执行官倪昕先生计划于公开市场动用个人资金,实施最高总额100万美元的增持股份计划。增持将自2026年8月31日开始进行。公告显示,倪昕先生此次增持基于其对公司未来发展前景和长期投资价值的信心。公司强调,任何股份回购的实施将取决于市场状况,并须遵守适用法律法规、监管要求及公司章程的规定。董事会表示,不保证回购的具体时间、数量或价格。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663010530","title":"亿腾嘉和(06998)董事会主席倪昕计划斥资最高100万美元增持公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2663010530","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663010530?lang=zh_cn&edition=full","pubTime":"2026-08-31 22:55","pubTimestamp":1788188100,"startTime":"0","endTime":"0","summary":"股份购买将自2026年8月31日起进行,预计总金额最高为100万美元。根据本公司所得资料及董事所知所信,倘若增持股份计划得以实施,本公司将继续维持已发行股份的足够公众持股量。董事会认为,建议股份购回符合本公司及其股东整体最佳利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1489981.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和(06998)董事会主席倪昕计划斥资最高100万美元增持公司股份","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1574","06998","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662096619","title":"亿腾嘉和(06998)发布中期业绩 期内亏损6587.6万元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2662096619","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662096619?lang=zh_cn&edition=full","pubTime":"2026-08-28 21:47","pubTimestamp":1787924825,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亿腾嘉和(06998)发布截至2026年6月30日止六个月业绩,该集团期内取得收入8.73亿元人民币,同比减少23.14%;期内亏损6587.6万元,同比盈转亏。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1488493.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1574","06998","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129787359","title":"亿腾嘉和2026年上半年营收8.73亿元,经调整净亏损0.33亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=1129787359","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1129787359?lang=zh_cn&edition=full","pubTime":"2026-08-28 20:48","pubTimestamp":1787921334,"startTime":"0","endTime":"0","summary":"2026年8月28日,亿腾嘉和发布2026年上半年财报。报告期内,公司实现营收8.73亿元,同比下降23.1%。经调整净亏损从上年同期的经调整净利润1.58亿元转为-0.33亿元,同比下滑120.9%。经营活动产生的现金流量净额达3.37亿元,相比上年同期的2.95亿元增长14.3%,显示出一定的现金流稳健性。报告期内整体毛利率为66.2%,基本与上年同期的66.9%保持平稳。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"亿腾嘉和2026年上半年营收8.73亿元,经调整净亏损0.33亿元","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661296505","title":"亿腾嘉和(06998.HK)盈警:预计中期净亏损6000万元至7000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2661296505","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661296505?lang=zh_cn&edition=full","pubTime":"2026-08-21 22:17","pubTimestamp":1787321822,"startTime":"0","endTime":"0","summary":"格隆汇8月21日丨亿腾嘉和发布公告,预期集团截至2026年6月30日止六个月将录得收入约人民币8.5亿元至9亿元,而截至2025年6月30日止六个月的收入约为人民币11.355亿元;及净亏损约人民币6000万元至人民币7000万元,而截至2025年6月30日止六个月的净利润约为人民币1.146亿元。 公告表示,由净利润转为净亏损主要归因于:i)万古霉素注射剂于2026年年中被纳入第十二批国家组织药品集中带量采购范围。创新是集团完成战略合并后的战略重点。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260821/32343532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1583","BK1574","06998","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661295216","title":"亿腾嘉和(06998.HK)发盈警,预期中期净亏损6000万元至7000万元 同比盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2661295216","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661295216?lang=zh_cn&edition=full","pubTime":"2026-08-21 22:05","pubTimestamp":1787321159,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","BK1583","06998","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138843347","title":"亿腾嘉和(06998)发出盈利警告:上半年预计由盈转亏至最高亏损70百万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1138843347","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1138843347?lang=zh_cn&edition=full","pubTime":"2026-08-21 22:01","pubTimestamp":1787320898,"startTime":"0","endTime":"0","summary":"2026年8月21日,亿腾嘉和医药集团有限公司发布盈利警告,预期截至2026年6月30日止六个月的主要财务数据如下:\\n\\n1. 收入预计介乎8.5亿元至9亿元,较2025年同期的11.36亿元下降。\\n\\n2. 净利润预计由2025年同期的1.15亿元转为净亏损60百万元至70百万元。\\n\\n公告同时显示,集团创新药业务上半年收入预计同比增长约50%。\\n\\n亿腾嘉和称,上述数据基于对未经审计综合管理账目进行的初步评估,最终业绩将在2026年8月底公布的中期业绩公告中披露。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136785464","title":"亿腾嘉和公告将于8月28日召开董事会审议中期业绩与派息事宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1136785464","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1136785464?lang=zh_cn&edition=full","pubTime":"2026-08-18 17:20","pubTimestamp":1787044829,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司(股票代码:06998)8月18日发布公告称,公司董事会已决定于2026年8月28日(星期五)召开会议。届时,董事会将审议并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩,并考虑是否建议派发中期股息(如有)。\n公告显示,公司董事会成员包括执行董事倪昕先生及韩淑华博士;非执行董事David Guowei Wang博士及于铁铭先生;以及独立非执行董事许庆博士、陈文先生及郑晶晶女士。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117179561","title":"亿腾嘉和(06998)GB268在乳腺癌Ib/II期试验完成首例给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1117179561","media":"公告速递","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1117179561?lang=zh_cn&edition=full","pubTime":"2026-08-06 22:30","pubTimestamp":1786026657,"startTime":"0","endTime":"0","summary":"2026年8月6日,亿腾嘉和医药集团有限公司发布自愿公告称,其PD-1/CTLA-4/VEGF三特异性抗体GB268在治疗局部晚期不可切除或转移性乳腺癌的Ib/II期临床试验,于2026年8月5日完成首例受试者给药。该研究包含三种治疗方案:GB268单药、GB268联合化疗的免疫方案,以及GB268联合抗体偶联药物的方案。主要研究终点为评估联合治疗的安全性与耐受性,包括剂量限制性毒性,并考察GB268单药及其多种联合方案在相应乳腺癌人群中的初步抗肿瘤活性。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657302406","title":"亿腾嘉和(06998):GB268 Ib/II期临床试验完成首例受试者给药","url":"https://stock-news.laohu8.com/highlight/detail?id=2657302406","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657302406?lang=zh_cn&edition=full","pubTime":"2026-08-06 22:24","pubTimestamp":1786026254,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亿腾嘉和 发布公告,本公司高度差异化创新的PD-1/CTLA-4/VEGF三特异性抗体GB268用于治疗局部晚期不可切除或转移性乳腺癌的Ib/II期临床试验于2026年8月5日成功完成首例受试者给药。该临床方案贯穿一线、后线全疗程阶段,为全方位拓展GB268应用范围迈出第一步,未来本公司亦计划在更多晚期实体瘤领域开展多项联合治疗临床研究。GB268单药I期临床数据计划于2026年第四季度在欧洲肿瘤内科学会公布。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477023.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","IBBQ","MDTX","BK1161","BK1583","IBBJ","PSYK","06998","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197524050","title":"亿腾嘉和更新7月股份变动月报表,股本总量保持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1197524050","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1197524050?lang=zh_cn&edition=full","pubTime":"2026-08-06 16:51","pubTimestamp":1786006317,"startTime":"0","endTime":"0","summary":"亿腾嘉和于2026年8月6日披露截至2026年7月31日的股份变动月报表。报告显示,公司法定注册股本维持3,000,000,000股,每股面值0.00002美元,合计60,000美元。截至本月底,总股本仍为2,014,041,774股,未发生总体增减变动。在股权激励方面,报告披露了多项购股权及受限制股份单位计划的最新进展。其中,2019年及2020年分别通过股东大会决议案所采纳的首次公开发售前/后的购股权计划和2023年购股权计划,总体期权数量在本月内无新增发行。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114642203","title":"亿腾嘉和(06998)景助达再许可协议终止 已向关联方累计支付6,000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114642203","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1114642203?lang=zh_cn&edition=full","pubTime":"2026-08-05 22:45","pubTimestamp":1785941156,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司8月5日公告,因Syndax Pharmaceuticals, Inc.向亿腾景昂药业(香港)有限公司发出终止通知,2013年4月18日签订的原许可协议即时终止。受此影响,泰州亿腾景昂药业股份有限公司无法继续向苏州亿腾药品销售有限公司授予景助达的商业化权利,导致双方于2023年5月9日签订的《2023年再许可协议》及其项下持续关连交易停止履行。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116846228","title":"亿腾嘉和回购20万股股份,总额约36.38万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1116846228","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116846228?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:56","pubTimestamp":1785239809,"startTime":"0","endTime":"0","summary":"亿腾嘉和医药集团有限公司于2026年7月28日公告披露,当日于香港联交所场内回购普通股合共200,000股,占回购前公司已发行股本约0.01%。本次回购每股价格介乎1.76港元至1.88港元,合计耗资约36.38万港元。回购后,公司已发行股本总数为2,014,041,774股,其中1,988,499,774股为已发行在外股份,库藏股数量增至25,542,000股。公司表示,本次交易已取得董事会正式授权并符合香港联交所上市规则及相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和回购20万股股份,总额约36.38万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654001377","title":"亿腾嘉和(06998.HK)7月28日斥资36.38万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654001377","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654001377?lang=zh_cn&edition=full","pubTime":"2026-07-28 19:45","pubTimestamp":1785239118,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1574","06998","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1194797343","title":"亿腾嘉和回购74,000股,总额约13.99万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1194797343","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1194797343?lang=zh_cn&edition=full","pubTime":"2026-07-27 19:45","pubTimestamp":1785152756,"startTime":"0","endTime":"0","summary":"亿腾嘉和于2026年7月27日发布翌日披露报表称,公司于当日在香港联交所回购普通股74,000股,占2026年7月24日现有已发行股本约0.004%。本次回购价格区间介乎每股港币1.85元至1.92元,总耗资约13.99万港元。回购后,公司已发行股份数由1,988,773,774股降至1,988,699,774股,库藏股增至25,342,000股。公告显示,回购根据公司于2026年6月26日通过的购回授权进行,可购回股份总数为199,074,827股。截至本次回购,已在交易所及其他交易所累计购回股份约2,048,500股,占该授权通过当日全数已发行股本的约0.1%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"亿腾嘉和回购74,000股,总额约13.99万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06998"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654463012","title":"亿腾嘉和(06998)7月27日耗资约13.99万港元回购7.4万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654463012","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654463012?lang=zh_cn&edition=full","pubTime":"2026-07-27 19:42","pubTimestamp":1785152555,"startTime":"0","endTime":"0","summary":"智通财经APP讯,亿腾嘉和(06998)公布,2026年7月27日耗资约13.99万港元回购7.4万股股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1472722.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK1583","06998","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654050636","title":"亿腾嘉和于7月24日斥资37.26万港元回购20万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654050636","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654050636?lang=zh_cn&edition=full","pubTime":"2026-07-26 09:37","pubTimestamp":1785029820,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n 亿腾嘉和(06998)发布公告,于2026年7月24日,该公司斥资37.26万港元回购20万股股份,每股回购价1.83-1.88港元。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:卢昱君","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-07-26/doc-inikawyp0571961.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["06998","BK1574","BK1583","BK1161"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0557},{"period":"1month","weight":-0.0529},{"period":"3month","weight":-0.0852},{"period":"6month","weight":-0.397},{"period":"1year","weight":-0.6515},{"period":"ytd","weight":-0.4633}],"compareEarnings":[{"period":"1week","weight":-0.0133},{"period":"1month","weight":-0.0268},{"period":"3month","weight":0.0023},{"period":"6month","weight":-0.0173},{"period":"1year","weight":-0.0073},{"period":"ytd","weight":-0.0125}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"亿腾嘉和医药集团有限公司(原名:嘉和生物药业(开曼)控股有限公司)是一家专注于生物制药业务的企业。该公司主营业务涵盖人用生物制药产品的研发、商业化及产业化。该公司产品管线包括来罗西利(GB491)、GB261、GB263T、英夫利西单抗(GB242)、Coprelotamab(GB221)、GB223、利妥昔单抗(GB241)等,涉及乳腺癌、肺癌、胃肠肿瘤及血液肿瘤等疾病领域。该公司主要在国内市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.069875},{"month":2,"riseRate":0.5,"avgChangeRate":0.016786},{"month":3,"riseRate":0.5,"avgChangeRate":0.013026},{"month":4,"riseRate":0.5,"avgChangeRate":-0.068745},{"month":5,"riseRate":0.5,"avgChangeRate":-0.031387},{"month":6,"riseRate":0.5,"avgChangeRate":0.007707},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.07514},{"month":8,"riseRate":0.333333,"avgChangeRate":0.079692},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.074575},{"month":10,"riseRate":0.4,"avgChangeRate":-0.052461},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.008673},{"month":12,"riseRate":0.666667,"avgChangeRate":0.044784}],"exchange":"SEHK","name":"亿腾嘉和","nameEN":"EDDING GENOR"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"亿腾嘉和(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供亿腾嘉和(06998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"亿腾嘉和,06998,亿腾嘉和股票,亿腾嘉和股票老虎,亿腾嘉和股票老虎国际,亿腾嘉和行情,亿腾嘉和股票行情,亿腾嘉和股价,亿腾嘉和股市,亿腾嘉和股票价格,亿腾嘉和股票交易,亿腾嘉和股票购买,亿腾嘉和股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"亿腾嘉和(06998)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供亿腾嘉和(06998)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}